A suboptimal response to the 2-dose COVID-19 vaccine series in the immunocompromised population prompted recommendations for a 3rd primary dose. We aimed to determine the humoral and cellular immune ...
In a recent study published in the Journal of Clinical Medicine, researchers investigated the B cell and humoral immune responses elicited against inactivated and recombinant severe acute respiratory ...
Figure 1A summarizes the characteristics of the patients incorporated in this study. This study included 154 nontransplant controls, 122 K recipients who had received the mRNA vaccine after KT, and 9 ...
In a recent study published in Clinical Infectious Diseases, researchers longitudinally evaluated humoral immune responses to the second and third (booster) doses of coronavirus disease 2019 (COVID-19 ...
Risk factors for in-hospital mortality in cancer patients hospitalized for COVID-19. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text ...
Antibody-mediated rejection (ABMR) remains the leading immunological cause of kidney allograft loss, yet its humoral origins are incompletely understood.